Abstract
Due to the inconsistent correlation of vancomycin trough concentrations with 24-hour area under the curve (AUC) and a desire to reduce rates of vancomycin-associated acute kidney injury, an institutional guideline was implemented by the Antimicrobial Stewardship Team in September 2017 to monitor vancomycin using AUC. Three stages were utilized to organize the process: preparation, implementation, and evaluation. The preparation stage was used to present literature to key stakeholders, and pharmacy meetings focused on the development of a dosing and monitoring guideline. Along with institution-wide education, the implementation stage included information technology development and support. The evaluation stage was comprised of quality improvement and clinical research. Future plans include dissemination of the results and analyses. Numerous lessons were learned due to barriers experienced during the process, but the transition was successful.
Original language | English |
---|---|
Pages (from-to) | 774-778 |
Number of pages | 5 |
Journal | Journal of Pharmacy Practice |
Volume | 33 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2020 |
Bibliographical note
Funding Information:The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The project described was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Funding Information:
The authors acknowledge the following individuals of the pharmacy work group at the University of Kentucky HealthCare who supported the implementation of the new therapeutic drug monitoring: Aaron Cook, PharmD, BCCP, BCPS, Ryan Crass, PharmD (Dr. Crass was a pharmacy resident at UK HealthCare during the preparation stage of this practice change and is currently a Clinical Translational Sciences Fellow at the University of Michigan College of Pharmacy), Krutika Mediwala, PharmD, BCPS (Dr. Mediwala was a pharmacy resident at UK HealthCare during the preparation stage of this practice change and is currently an Infectious Diseases/Antimicrobial Stewardship Clinical Pharmacist at MUSC Health), and Dwayne Pierce, PharmD, BCPS. The authors would also like to thank the Infectious Diseases physician faculty for their support and involvement in this process implementation. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The project described was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© The Author(s) 2019.
Keywords
- acute kidney injury
- area under the curve
- therapeutic drug monitoring
- vancomycin
ASJC Scopus subject areas
- Pharmacy
- Pharmacology (medical)